Litcius/Paper detail

Mechanisms Driving Immune-Related Adverse Events in Cancer Patients Treated with Immune Checkpoint Inhibitors

David Jungpa Lee, Howard J. Lee, Jocelyn R. Farmer, Kerry L. Reynolds

2021Current Cardiology Reports94 citationsDOI

Topics & Concepts

MedicineImmune systemAdverse effectCancerImmune checkpointIpilimumabImmunologyInternal medicineImmunotherapyCancer Immunotherapy and BiomarkersMultiple and Secondary Primary CancersLung Cancer Research Studies
Mechanisms Driving Immune-Related Adverse Events in Cancer Patients Treated with Immune Checkpoint Inhibitors | Litcius